Order Article Reprints

Jerzak KJ, Kumar A, Boileau J-F, Bouganim N, Brezden-Masley C, Cao JQ, Cescon DW, Chia S, Edwards S, Joy AA, et al. Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Metastatic Breast Cancer 2025. Current Oncology. 2026; 33(2):106. https://doi.org/10.3390/curroncol33020106

Jerzak, Katarzyna J., Aalok Kumar, Jean-François Boileau, Nathaniel Bouganim, Christine Brezden-Masley, Jeffrey Q. Cao, David W. Cescon, Stephen Chia, Scott Edwards, Anil Abraham Joy, and et al. 2026. "Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Metastatic Breast Cancer 2025" Current Oncology 33, no. 2: 106. https://doi.org/10.3390/curroncol33020106

Jerzak, K. J., Kumar, A., Boileau, J.-F., Bouganim, N., Brezden-Masley, C., Cao, J. Q., Cescon, D. W., Chia, S., Edwards, S., Joy, A. A., Laing, K., LeVasseur, N., Lupichuk, S., Sehdev, S., Simmons, C., Webster, M., Gelmon, K. A., Manna, M., & on behalf of patient advocacy, Breast Cancer Canada. (2026). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Metastatic Breast Cancer 2025. Current Oncology, 33(2), 106. https://doi.org/10.3390/curroncol33020106